Close Menu

NEW YORK — DiamiR said on Wednesday that it has received a $492,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to investigate the use of microRNAs as biomarkers of neurodegeneration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.